Chilblain lupus erythematosus in an adolescent girl

Bansal, Shikha; Goel, Aditya

doi:10.4103/2229-5178.144522

Cited by 8 publications

(4 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Both the diseases arising from a mutation in ATP2A2 gene exhibit loose skin as a phenotypic contribution to the affected individual. Lastly, previous reports show clear progression of chilblain lupus erythematosus to systemic lupus erythematosus (SLE) (Bansal and Goel 2014), with around 20% individuals developing SLE (Hedrich et al 2008).…”

Section: Disease-snp Bipartite Network (Dsn)mentioning

confidence: 86%

DermaGene and VitmiRS: a comprehensive systems analysis of genetic dermatological disorders

et al. 2018

View full text Add to dashboard Cite

show abstract

Section: Disease-snp Bipartite Network (Dsn)mentioning

confidence: 86%

DermaGene and VitmiRS: a comprehensive systems analysis of genetic dermatological disorders

et al. 2018

View full text Add to dashboard Cite

show abstract

“…The risk of developing systemic LE is up to 20% in patients with chilblain LE; hence, it should be carefully followed up. 15…”

Section: Response To Anti-le Therapymentioning

confidence: 99%

Skin Changes in Lupus Erythematosus: A Concise Review Lupus Erythematosus and Skin-demystifying the Features

Gupta,

Kumaran

2024

Indian Journal of Rheumatology

View full text Add to dashboard Cite

Lupus erythematosus is an autoimmune disease characterised by the formation of various autoantibodies, leading to the involvement of numerous organ systems like the nervous system, renal system, and cutaneous involvement. Cutaneous involvement is the second most common manifestation after musculoskeletal involvement and can range from minor involvement to severe disabling sequelae. The type of skin manifestation can sometimes predict the underlying systemic involvement, as most patients of acute lupus erythematosus have concomitant systemic involvement in contrast to limited chronic cutaneous LE, which has a low incidence of systemic involvement. The cutaneous manifestations have been included in the Systemic Lupus International Collaborating Clinics (SLICC) and American College of Rheumatology criteria for ease in diagnosing lupus erythematosus patients. Herein, we present a review of various cutaneous manifestations seen in association with systemic lupus erythematosus (SLE) patients and their specific management, which can ease the early diagnosis of the patients and triage the patients that will need close follow-up for systemic involvement.

show abstract

“…Малые критерии: наличие других кожных проявлений ХККВ или СКВ; ответ на терапию красной волчанки; отрицательные результаты тестирования на криоглобулины и холодовые агглютинины. Диагноз волчанки обморожения подтверждается при выявлении как большого, так и одного из малых критериев [36,37].…”

Section: волчанка обморожения (Chilblain Lupus)unclassified

Skin lesions in systemic lupus erythematosus. Part 2: clinical and histological features

Shumilova¹,

Travkina²,

Reshetnyak³

2022

Sovremennaâ revmatologiâ

View full text Add to dashboard Cite

Skin lesions in systemic lupus erythematosus (SLE) are not just a cosmetic defect, accompanied by a deterioration in the quality of life and psychological discomfort, but, possibly, the first sign of a systemic course of disease. Systemic involvement can develop in patients with almost any type of cutaneous lupus erythematosus (CLE), requiring the study of CLE in combination with SLE. Dermatologists are the first to face with skin manifestations of SLE, while other organs and systems affection leads the patient to a rheumatologist. It is important to understand that skin lesions do not cause irreversible organ damage, but continuity of therapeutic approaches between a dermatologist and a rheumatologist is necessary. The review presents the clinical signs, diagnostic features and histological characteristics of CLE.

show abstract

Chilblain lupus erythematosus in an adolescent girl

Cited by 8 publications

References 9 publications

DermaGene and VitmiRS: a comprehensive systems analysis of genetic dermatological disorders

DermaGene and VitmiRS: a comprehensive systems analysis of genetic dermatological disorders

Skin Changes in Lupus Erythematosus: A Concise Review Lupus Erythematosus and Skin-demystifying the Features

Skin lesions in systemic lupus erythematosus. Part 2: clinical and histological features

Contact Info

Product

Resources

About